Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes

Abstract Secreted phosphosprotein 1 (SPP1)High tumor‐associated macrophages (TAM) are abundant tumor myeloid cells that are immunosuppressive, pro‐tumorigenic, and have a highly negative prognostic factor. Despite this, there is a lack of efficient TAM‐specific therapeutics capable of reducing SPP1...

Full description

Saved in:
Bibliographic Details
Main Authors: Benan Kartal, Christopher S. Garris, Hyung Shik Kim, Rainer H. Kohler, Jasmine Carrothers, Elias A. Halabi, Yoshiko Iwamoto, Anne‐Gaëlle Goubet, Yuxuan Xie, Pratyaksha Wirapati, Mikaël J. Pittet, Ralph Weissleder
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202410360
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582743630807040
author Benan Kartal
Christopher S. Garris
Hyung Shik Kim
Rainer H. Kohler
Jasmine Carrothers
Elias A. Halabi
Yoshiko Iwamoto
Anne‐Gaëlle Goubet
Yuxuan Xie
Pratyaksha Wirapati
Mikaël J. Pittet
Ralph Weissleder
author_facet Benan Kartal
Christopher S. Garris
Hyung Shik Kim
Rainer H. Kohler
Jasmine Carrothers
Elias A. Halabi
Yoshiko Iwamoto
Anne‐Gaëlle Goubet
Yuxuan Xie
Pratyaksha Wirapati
Mikaël J. Pittet
Ralph Weissleder
author_sort Benan Kartal
collection DOAJ
description Abstract Secreted phosphosprotein 1 (SPP1)High tumor‐associated macrophages (TAM) are abundant tumor myeloid cells that are immunosuppressive, pro‐tumorigenic, and have a highly negative prognostic factor. Despite this, there is a lack of efficient TAM‐specific therapeutics capable of reducing SPP1 expression. Here, on a phenotypic screen is reported to identify small molecule SPP1 modulators in macrophages. Several hits and incorporated them into a TAM‐avid systemic nanoformulation are identified. It is shown that the lead compound (CANDI460) can down‐regulate SPP1 in vitro and in vivo and lead to tumor remissions in different murine models. These findings are important as they offer a promising avenue for developing novel therapeutic strategies targeting TAM.
format Article
id doaj-art-463f2aee13d64a50ab0533bab46ace65
institution Kabale University
issn 2198-3844
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-463f2aee13d64a50ab0533bab46ace652025-01-29T09:50:19ZengWileyAdvanced Science2198-38442025-01-01124n/an/a10.1002/advs.202410360Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor SizesBenan Kartal0Christopher S. Garris1Hyung Shik Kim2Rainer H. Kohler3Jasmine Carrothers4Elias A. Halabi5Yoshiko Iwamoto6Anne‐Gaëlle Goubet7Yuxuan Xie8Pratyaksha Wirapati9Mikaël J. Pittet10Ralph Weissleder11Center for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USACenter for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USACenter for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USACenter for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USACenter for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USACenter for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USACenter for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USADepartment of Pathology and Immunology University of Geneva Geneva 1211 SwitzerlandDepartment of Pathology and Immunology University of Geneva Geneva 1211 SwitzerlandDepartment of Pathology and Immunology University of Geneva Geneva 1211 SwitzerlandDepartment of Pathology and Immunology University of Geneva Geneva 1211 SwitzerlandCenter for Systems Biology Massachusetts General Hospital 185 Cambridge St, CPZN 5206 Boston MA 02114 USAAbstract Secreted phosphosprotein 1 (SPP1)High tumor‐associated macrophages (TAM) are abundant tumor myeloid cells that are immunosuppressive, pro‐tumorigenic, and have a highly negative prognostic factor. Despite this, there is a lack of efficient TAM‐specific therapeutics capable of reducing SPP1 expression. Here, on a phenotypic screen is reported to identify small molecule SPP1 modulators in macrophages. Several hits and incorporated them into a TAM‐avid systemic nanoformulation are identified. It is shown that the lead compound (CANDI460) can down‐regulate SPP1 in vitro and in vivo and lead to tumor remissions in different murine models. These findings are important as they offer a promising avenue for developing novel therapeutic strategies targeting TAM.https://doi.org/10.1002/advs.202410360cancermacrophagenanoparticlesSPP1
spellingShingle Benan Kartal
Christopher S. Garris
Hyung Shik Kim
Rainer H. Kohler
Jasmine Carrothers
Elias A. Halabi
Yoshiko Iwamoto
Anne‐Gaëlle Goubet
Yuxuan Xie
Pratyaksha Wirapati
Mikaël J. Pittet
Ralph Weissleder
Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes
Advanced Science
cancer
macrophage
nanoparticles
SPP1
title Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes
title_full Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes
title_fullStr Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes
title_full_unstemmed Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes
title_short Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes
title_sort targeted spp1 inhibition of tumor associated myeloid cells effectively decreases tumor sizes
topic cancer
macrophage
nanoparticles
SPP1
url https://doi.org/10.1002/advs.202410360
work_keys_str_mv AT benankartal targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT christophersgarris targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT hyungshikkim targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT rainerhkohler targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT jasminecarrothers targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT eliasahalabi targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT yoshikoiwamoto targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT annegaellegoubet targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT yuxuanxie targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT pratyakshawirapati targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT mikaeljpittet targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes
AT ralphweissleder targetedspp1inhibitionoftumorassociatedmyeloidcellseffectivelydecreasestumorsizes